NonprofitsWittek Research Foundation For Hypertrophic Cardiomyopathy Inc

Medical Research

Wittek Research Foundation For Hypertrophic Cardiomyopathy Inc

TENAFLY, NJ

Total revenue

$74K

Total expenses

$41K

Net assets

$71K

Grants received

$60K

2 grants

EIN

861682122

Tax year

2023

Mission

Dedicated to supporting research that will transform the prevention, diagnosis, and treatment of hypertrophic cardiomyopathy.

Financials

FY 2023

Revenue

Contributions & grants$74K
Program service revenue
Investment income
Other revenue
Total revenue$74K

Expenses

Grants paid
Salaries & benefits
Fundraising
Other expenses$7K
Total expenses$41K
Total assets$71K
Net assets$71K

People

3 listed

NameRoleCompensation

PAMELA COHEN MD

PRESIDENT AND FOUNDER

Board

20 hrs/wk

SAM BLUMENSTYK JD

TREASURER

Board

2 hrs/wk

PAMELA GOLDSTEIN JD

SECRETARY

Board

2 hrs/wk

Grants received

Showing 2 of 2

FromAmountPurposeYear
$30K
UNRESTRICTED GENERAL SUPPORT
2023
$30K
UNRESTRICTED GENERAL SUPPORT
2022

Funded by

$60K from 1 funder · 2 grants · 2022–2023

Morgan Stanley Global Impact Funding Trust Inc

$60K · 2 grants · 2022–2023

Details

EIN861682122
NTEE codeH43
Subsection03
Ruling date2021-07
WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC — Mission, Financials & Grants Received | Grantivo